Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCMFlag_hsE2F4 (#RDB06786)

Expression vector of human E2F4.

Alternative name SET-0113_9-1
Clone info. Expression vector of human E2F4. Expression has not yet been confirmed.
Comment PCR cloning, forward primer: gcggaggccgggccacaggc; reverse primer: tcagaggttgagaacaggcacatc.
Vector backbone pCMV_S-FLAG (RDB05956) (Plasmid)
Size of vector backbone 5.5 kb
Selectable markers Amp^r (E. coli), Neo^r (mammalian cell)
Growth conditions 37C, LB+Amp
Gene/insert name Human E2F transcription factor 4,p107/p103-binding cDNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
MTA, for use for for-profit purpose [Word]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL in any publication.
Additional terms and conditions:
Regrding pRc/CMV:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
提供同意書 (MTA, 営利目的用)[Word]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 発表に際し、理研BRCから入手したことを明記すること。
付加的使用条件:
pRc/CMVについて:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.

Catalog # Resource name Shipping form Fee
RDB06786 pCMFlag_hsE2F4 DNA solution JPY 9,460 (not-for-profit academic purpose)
JPY 18,920 (for-profit-research purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pCMFlag_hsE2F4 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06786).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB12837_A4Hb.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV-Forward
Sequence file: RDB12837_A4Hba.seq check
>06786_12837_A4Hb_CMV-Foward_C07_07.ab1
    1 CGTTCCTCCG CCCATTGACG CAATGGGCGG TAGGCGTGTA CGGTGGGAGG TCTATATAAG
   61 CAGAGCTCTC TGGCTAACTA GAGAACCCAC TGCTTACTGG CTTATCGAAA TTAATACGAC
  121 TCACTATAGG GAGACCCAAG CTGAATTCAC CATGGACTAC AAGGACGATG ACGATAAGGC
  181 GGCCGCGGAG GCCGGGCCAC AGGCGCCGCC GCCCCCGGGC ACTCCAAGCC GGCACGAAAA
  241 GAGCCTGGGA CTGCTCACCA CCAAGTTCGT GTCCCTTCTG CAGGAGGCCA AGGACGGCGT
  301 GCTTGACCTC AAGCTGGCAG CTGACACCCT AGCTGTACGC CAGAAGCGGC GGATTTACGA
  361 CATTACCAAT GTTTTGGAAG GTATCGGGCT AATCGAGAAA AAGTCCAAGA ACAGCATCCA
  421 GTGGAAGGGT GTGGGGCCTG GCTGCAATAC CCGGGAGATT GCTGACAAAC TGATTGAGCT
  481 CAAGGCAGAG ATCGAGGAGC TGCAGCAGCG GGAGCAAGAA CTAGACCAGC ACAAGGTGTG
  541 GGTGCAGCAG AGCATCCGGA ACGTCACAGA GGACGTGCAG AACAGCTGTT TGGCCTACGT
  601 CACTCATGAG GACATCTGCA GATGCTTTGC TGGAGATACC CTCTTGGCCA TCCGGGCCCC
  661 ATCAGGCACC AGCCTGGAGG TGCCCATCCC AGAGGGTCTC AATGGGCAGA AGAAGTACCA
  721 GATTCACCTG AAGAGTGTGA GTGGTCCCAT TGAGGTTCTG CTGGTGAACA AGGAGGCATG
  781 GAGCTCACCC CCTGTGGCTG TGCCTGTGCC ACCACCTGAA GATTTGCTCC AGAGCCCATC
  841 TGCTGTTTCT ACACCTCCAC CTCTGCCCAA GCCTGCCCTA GCCCAGTCCC AGGAAGCCTC
  901 ACGTCCAAAT AGTCCTCAGC TCACTCCCAC TGCTGTCCCT GGCAGTGCAG AAGTCCAGGG
  961 AATGGCTGGG CCCAGCAGCT GAGATCACAG TGAGTGGCGG GCCCTGGGAC TGATAGCAAA
 1021 GGGACAGTGG TGAGCTCAGT TCACTCCCCA CTGGGCCCCA ACACACTGGA CACCCGGGCA
 1081 CTGCAGTCTT CTGCCTTGCT TGGACAGCCA GCCAGCCAGG CAGCAAGGCA GGCCAGGCCA
1141 GG
//
Primer: BGH_rev
Sequence file: RDB12837_A4Hbb.seq check
>06786_12837_A4Hb_BGHrev_D07_10.ab1
    1 GCCTTACCCA TTAGGGTGAA CTATAGAATA GGGCCCTCTA GATGCATGCT CGAGCGGCTC
   61 AGAGGTTGAG AACAGGCACA TCAAAGAGGT CACAGACACC TTCACTCTCG TCCAGGTTGT
  121 AGATATAATC GTGGTCTCCC GGGGGTGGAG AAAGACGAAG CAGAGGGGCA AACACTTCTG
  181 AGGACATCAA CTCCTCCAGC AGCTCCGAGC TCATGCACTC TCGTGTGGGA TCAAAGATTT
  241 CTGACAGCTC TTTGGGGAGT TCCAAAACAC CTGTGGGGTC TGCCTTGATG GGCTCAAAGG
  301 AGGTAGAAGG GTTGGGTCCG GACGAACTGC TGCTGTTACT GTTGCTGCTG CTGCTGCTGC
  361 TGCTGCTGCT GCTGCTGCTG CTGTCCAGCA GGGCAGAAGA CTGCAGTGGC CGGGTGTCCA
  421 GTGTTGTTGG GCCCAGTGGG AGTGAACTGA GCTCACCACT GTCCTTGCTA TCAGTCCCAG
  481 GGCCGCCACT CACTGTGATC TCAGCTGCTG GGCCAGCCAT TCCCTGGACT TCTGCACTGC
  541 CAGGGACAGC AGTGGGAGTG AGCTGAGGAC TATTTGGACG TGAGGCTTCC TGGGACTGGG
  601 CTAGGGCAGG CTTGGGCAGA GGTGGAGGTG TAGAAACAGC AGATGGGCTC TGGAGCAAAT
  661 CTTCAGGTGG TGGCACAGGC ACAGCCACAG GGGGTGAGCT CCATGCCTCC TTGTTCACCA
  721 GCAGAACCTC AATGGGACCA CTCACACTCT TCAGGTGAAT CTGGTACTTC TTCTGCCCAT
  781 TGAGACCCTC TGGGATGGGC ACCTCCAGGC TGGTGCCTGA TGGGGCCCGG ATGGCCAAGA
  841 GGGTATCTCC AGCAAAGCAT CTGCAGATGT CCTCATGAGT GACGTAGGCC AAACAGCTGT
  901 TCTGCACGTC CTCTGTGACG TTCCGGATGC TCTGCTGCAC CCACACCTTG TGCTGGTCTA
  961 GTTCTTGCTC CCGCTGCTGC AGCTCCTCGA TCTCTGCCTT GAGCTCAATC AGTTGTCAGC
 1021 AAATCTCCCG GGTATTGCAG CCCAGGGCCC CACACCCTTT CACTGGAATG CTGGTTCTTG
 1081 GACTTTTTTC TCGATTAGCC CGGATTACCC TCCAAACATG GTTAATGTTC GTAAATCCCG
1141 TCCGCGCTTC CTTGC
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles